Myovant and Pfizer’s uterine fibroids med scores FDA nod, setting up showdown with AbbVie

Fresh off the back of Myovant Sciences’ first FDA win for relugolix in prostate cancer late last year, the Swiss pharma can now add a second indication to its flagship drug’s resume.  The U.S. FDA on Wednesday approved Myovant’s relugolix in combination with two hormone drugs as the first once-daily treatment for heavy menstrual bleeding linked to… Read More: Myovant and Pfizer’s uterine fibroids med scores FDA nod, setting… »

After Two Seasons, Who Killed Sara? Fans Are Convinced Sara Is Actually Alive

Spoilers ahead for Who Killed Sara? Season Two. There’s a lot of uncertainty in this modern world of ours, but here’s one thing I know for sure: years from now, we’ll still be asking who killed Sara. It is, quite simply, the mystery of our time. Over 55 million Netflix users tuned into the first… Read More: After Two Seasons, Who Killed Sara? Fans Are Convinced Sara… »